Time To Treatment Augmentation Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Newly Initiated On Long Acting Muscarinic Agents (lama) Or Inhaled Corticosteroid (ics) And Long Acting Beta-2 Agonist (laba) Combination Therapy

被引：0
|
作者：
Patel, J. [1 ]
Mapel, D. W. [2 ]
Roberts, M. H. [2 ]
Sama, S. [3 ]
Gilmore, J. [3 ]
Sundaresan, D. [3 ]
Laliberte, F. [4 ]
Pilon, D. [5 ]
Lefebvre, P. [5 ]
Duh, M. [6 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Lovelace Clin Fdn, Albuquerque, NM USA
[3] Reliant Med Grp, Worcester, MA USA
[4] Grp Anal Ltee, Montreal, PQ, Canada
[5] Grp Anal Ltee, Montreal, PQ, Canada
[6] Anal Grp Inc, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5774
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)
    Horita, Nobuyuki
    Goto, Atsushi
    Shibata, Yuji
    Ota, Erika
    Nakashima, Kentaro
    Nagai, Kenjiro
    Kaneko, Takeshi
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (02):
  • [2] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
    Fukuda, Nobuhiko
    Horita, Nobuyuki
    Kaneko, Ayami
    Goto, Atsushi
    Kaneko, Takeshi
    Ota, Erika
    Kew, Kayleigh M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [3] Adherence To Current Guidelines For Chronic Obstructive Pulmonary Disease (COPD) In Subjects Treated With Combination Of Long-Acting Beta2-Agonist (LABA), Long-Acting Muscarinic Antagonist (LAMA) Or Inhaled Corticosteroids (ics)
    Asche, C. V.
    Leader, S.
    Plauschinat, C.
    Raparla, S.
    Yan, M.
    Ye, X.
    Young, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [4] ADHERENCE TO CURRENT GUIDELINES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SUBJECTS TREATED WITH COMBINATION OF LONG-ACTING B2-AGONIST (LABA), LONG-ACTING MUSCARINIC ANTAGONIST (LAMA) OR INHALED CORTICOSTEROIDS (ICS)
    Asche, C.
    Leader, S.
    Plauschinat, C.
    Raparla, S.
    Ye, X.
    Yan, M.
    Young, D.
    VALUE IN HEALTH, 2011, 14 (07) : A492 - A492
  • [5] The role of fixed dose combinations of inhaled cortikosteroids, long acting beta-2 agonists, and long acting muscarinic antagonists (ICS/LABA/LAMA) in the treatment of asthma
    Metan, Esra Unsay
    Bavbek, Sevim
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (03): : 369 - 379
  • [6] Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
    Yuasa, Mizuki
    Tanaka, Yosuke
    Tanaka, Tohru
    Kashiwada, Takeru
    Taniuchi, Namiko
    Saito, Yoshinobu
    Seike, Masahiro
    Hino, Mitsunori
    Gemma, Akihiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [7] Arterial stiffness is reduced by combination inhaled corticosteroid/long acting beta-2 agonist therapy in patients with COPD
    Sabit, R.
    Bolton, C. E.
    Allanby, C.
    Cockcroft, J. R.
    Shale, D. J.
    THORAX, 2007, 62 : A142 - A142
  • [8] The Effect of Extra Fine Medium-dose Inhaled Corticosteroid/Long-Acting Beta-2 Agonist/Long-Acting Muscarinic Antagonist (ICS/LABA/LAMA) on Distal Airway Indices Using Functional Respiratory Imaging in Patients With Symptomatic COPD on ICS/LABA
    Lavon, B. R.
    Guasconi, A.
    Georges, G.
    Bates, J. H.
    Galkin, D.
    Muchmore, P.
    Skloot, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Effectiveness Of Inhaled Corticosteroid/Long-Acting β2-Agonist (ICS/LABA) Combination Therapies Among Chronic Obstructive Pulmonary Disease (COPD) Patients Stratified By Pre-Therapy Short-Acting β2-Agonist (SABA) Use
    Roberts, M. H.
    Mapel, D. W.
    Blanchette, C. M.
    Ramachandran, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
12345